Photo: Colossal Biosciences A biotechnology start-up working to bring back animals from extinction has raised $200m (€194m) at a valuation of $10.2bn, more than six times its valuation just two ...

a biotech startup looking to resurrect a select number of animal species that no longer roam our Earth. Founded in 2021, the company’s eye-catching “de-extinction” mission has caught the ...

An oxygen sensor protein protects the enzymatic machinery of biological nitrogen fixation from serious damage, and its use in biotechnology could help to reduce the use of synthetic fertilizer in ...

(Tune Photos) Tune Therapeutics, a biotech company with headquarters in ... primates and reduce the levels of LDL cholesterol in the animals. A single treatment provided an ongoing reduction ...

“With evolutionary advances, it is possible, if not probable, that they might develop ways to breathe outside of water and eventually hunt terrestrial animals like deer, sheep, and other mammals – ...

(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...

In 2024, Fierce Biotech reported 192 industry layoff rounds, which is 3% higher than in 2023, when 187 rounds were tallied. Rounds are reported as they are disclosed and are not combined per ...

Re­gen­eron, mak­er of the block­buster oph­thal­mol­o­gy med­i­cine Eylea, has ac­quired an oc­u­lar biotech, the large bio­phar­ma con­firmed to End­points News on Thurs­day.

2024 was the year of the pri­vate megaround. Nine-fig­ure fi­nanc­ings dom­i­nat­ed biotech’s ven­ture fund­ing land­scape, with 96 such rounds tal­lied by End­points News. The bevy … ...

Carmell acquires Elevai Skincare, adding $2.5M in annual revenue and advanced exosome technology to its portfolio. Deal includes $1.1M in equity, $57K in cash, and earnouts tied to sales and ...